BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 940021)

  • 1. Effective long-term treatment of pseudohypoparathyroidism with oral 1alpha-hydroxy- and 1,25-dihydroxy-cholecalciferol.
    Werder EA; Kind HP; Egert F; Fischer JA; Prader A
    J Pediatr; 1976 Aug; 89(2):266-8. PubMed ID: 940021
    [No Abstract]   [Full Text] [Related]  

  • 2. Probable autosomal recessive inheritance in a family with Albright's hereditary osteodystrophy and an evaluation of the genetics of the disorder.
    Cederbaum SD; Lippe BM
    Am J Hum Genet; 1973 Nov; 25(6):638-45. PubMed ID: 4359274
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of the use of newer analogs of vitamin D in the management of renal osteodystrophy.
    Coburn JW; Brickman AS
    Adv Exp Med Biol; 1978; 103():473-86. PubMed ID: 362852
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy.
    Chesney RW; Hamstra A; Jax DK; Mazess RB; DeLuca HF
    Contrib Nephrol; 1980; 18():55-71. PubMed ID: 7353380
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
    Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE
    J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of pseudohypoparathyroidism: an informative family study.
    Barr DG; Stirling HF; Darling JA
    Arch Dis Child; 1994 Apr; 70(4):337-8. PubMed ID: 8185370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
    Lawoyin S; Norman DA; Zerwekh JE; Breslau NA; Pak CY
    J Clin Endocrinol Metab; 1979 Nov; 49(5):783-6. PubMed ID: 489718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: 1,25-Dihydroxyvitamin D3 and pseudohypoparathyroidism.
    Sinha TK; Bell NH
    N Engl J Med; 1976 Mar; 294(11):612. PubMed ID: 1246249
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of pseudovitamin D deficiency-like rickets in an infant treated with 1,25-dihydroxycholecalciferol. Preliminary note.
    Vecchio F; Carnevale F; Paganetti G; di Bitonto G; Marinelli G
    J Inherit Metab Dis; 1978; 1(4):183-5. PubMed ID: 117256
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH; Goldstein DA; Massry SG
    Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol.
    Chan JC; DeLuca HR
    JAMA; 1979 Mar; 241(12):1242-4. PubMed ID: 762789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of 1,25-dihydroxycholecalciferol in normal and uraemic man.
    Coburn JW; Brickman AS; Massry SG; Singer FR; Norman AW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):210-6. PubMed ID: 4802387
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that different vitamin D sterols have qualitatively different effects in man.
    Rasmussen H; Bordier P
    Contrib Nephrol; 1980; 18():184-91. PubMed ID: 7353375
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to vitamin D and parathyroid hormone.
    Moses AM
    N Engl J Med; 1978 Aug; 299(8):423-4. PubMed ID: 209328
    [No Abstract]   [Full Text] [Related]  

  • 16. Concurrence of features of pseudohypoparathyroidism, pseudopseudohypoparathyroidism and basal-cell nevus syndrome.
    Chopra IJ; Nugent CA
    Am J Med Sci; 1970 Sep; 260(3):171-83. PubMed ID: 5480625
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs.
    Keck E; Gollnick B; Reinhardt D; Karch D; Peerenboom H; Krüskemper HL
    Eur J Pediatr; 1982 Sep; 139(1):52-5. PubMed ID: 7173258
    [No Abstract]   [Full Text] [Related]  

  • 18. [GNAS1 gene abnormality in pseudohypoparathyroidism I a].
    Ozono K
    Clin Calcium; 2007 Aug; 17(8):1214-9. PubMed ID: 17660618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: The pieces of a vitamin D puzzle fall into place--almost!
    Wright DR
    N Engl J Med; 1975 Oct; 293(17):872-3. PubMed ID: 170517
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.